In 2016, results of an important randomized trial demonstrated that patients undergoing chemotherapy who reported symptoms electronically have a better quality of life than those receiving usual care. Now, a significant survival improvement for patients in the experimental arm of this study has been reported. The emphasis of this survival benefit is 'culturally' positive, promoting the adoption of patient-reported outcomes in clinical practice.

中文翻译：

---

成果研究：将PRO整合到临床中-总体生存与否，还是值得的，

2016年，一项重要的随机试验结果表明，接受化学疗法治疗且以电子方式报告症状的患者的生活质量要高于接受常规护理的患者。现在，已经报道了该研究实验组中患者的显着生存改善。这种生存益处的重点是“文化上”积极的，从而促进了患者报告的临床实践结果的采用。